Stericycle Past Earnings Performance

NasdaqGS:SRCL Revenue, expenses and earnings (USD Millions)
Date	Revenue	Earnings	G+A Expenses
31 Dec 23	2,659	-21	707
30 Sep 23	2,678	-4	676
30 Jun 23	2,715	22	620
31 Mar 23	2,725	81	680
31 Dec 22	2,705	56	707
30 Sep 22	2,692	7	707
30 Jun 22	2,650	-87	700
31 Mar 22	2,643	-68	686
31 Dec 21	2,647	-28	716
30 Sep 21	2,646	38	634
30 Jun 21	2,633	23	631
31 Mar 21	2,559	-11	620
31 Dec 20	2,676	-57	730
30 Sep 20	2,820	-325	677
30 Jun 20	3,016	-303	698
31 Mar 20	3,264	-329	753
31 Dec 19	3,309	-347	854
30 Sep 19	3,362	-446	810
30 Jun 19	3,384	-369	784
31 Mar 19	3,421	-312	816
31 Dec 18	3,486	-253	1,043
30 Sep 18	3,521	148	826
30 Jun 18	3,549	166	812
31 Mar 18	3,583	-9	814
31 Dec 17	3,581	23	840
30 Sep 17	3,599	-47	987
30 Jun 17	3,607	-21	1,025
31 Mar 17	3,581	165	965
31 Dec 16	3,562	178	777
30 Sep 16	3,544	236	715
30 Jun 16	3,373	244	661
31 Mar 16	3,197	295	605
31 Dec 15	2,986	257	594
30 Sep 15	2,775	269	506
30 Jun 15	2,724	282	495
31 Mar 15	2,649	276	482
31 Dec 14	2,556	326	434
30 Sep 14	2,447	322	428
30 Jun 14	2,313	320	408
31 Mar 14	2,199	316	384
31 Dec 13	2,143	311	380
30 Sep 13	2,079	303	359
30 Jun 13	2,024	288	353

Quality Earnings: SRCL is currently unprofitable.

Growing Profit Margin: SRCL is currently unprofitable.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: SRCL is unprofitable, but has reduced losses over the past 5 years at a rate of 60.7% per year.

Accelerating Growth: Unable to compare SRCL's earnings growth over the past year to its 5-year average as it is currently unprofitable

Return on Equity

Return on Assets

Return on Capital Employed

Discover strong past performing companies

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Stericycle Past Earnings Performance

Past criteria checks 0/6

Key information

Recent past performance updates

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

Stericycle, Inc. Reports Impairment Changes for the Second Quarter Ended June 30, 2023

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Full year 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Stericycle's (NASDAQ:SRCL) Conservative Accounting Might Explain Soft Earnings

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

Recent updates

Stericycle, Inc., Annual General Meeting, May 21, 2024

We Think Stericycle (NASDAQ:SRCL) Can Stay On Top Of Its Debt

President exercised options and sold US$615k worth of stock

President exercised options and sold US$808k worth of stock

Is There An Opportunity With Stericycle, Inc.'s (NASDAQ:SRCL) 47% Undervaluation?

Stericycle: Earnings Beat And Above-Expectations Guidance Reinforce My Buy Rating

Price target increased by 15% to US$61.83

Returns On Capital At Stericycle (NASDAQ:SRCL) Paint A Concerning Picture

Stericycle, Inc.'s (NASDAQ:SRCL) Shares May Have Run Too Fast Too Soon

We Think Stericycle (NASDAQ:SRCL) Can Stay On Top Of Its Debt

Stericycle, Inc. (NASDAQ:SRCL) Shares Could Be 44% Below Their Intrinsic Value Estimate

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

Stericycle (NASDAQ:SRCL) Hasn't Managed To Accelerate Its Returns

Consensus EPS estimates fall by 10%

Here's Why Stericycle (NASDAQ:SRCL) Can Manage Its Debt Responsibly

Stericycle, Inc. Reports Impairment Changes for the Second Quarter Ended June 30, 2023

Consensus EPS estimates fall by 49%

Is There An Opportunity With Stericycle, Inc.'s (NASDAQ:SRCL) 37% Undervaluation?

Stericycle (NASDAQ:SRCL) Will Be Hoping To Turn Its Returns On Capital Around

Stericycle (NASDAQ:SRCL) Seems To Use Debt Quite Sensibly

Executive VP & Chief People Officer recently bought US$309k worth of stock

Enviri Corporation Reaches an Amicable Agreement with Stericycle, Inc

Stericycle, Inc. Approves the Election of Victoria L. Dolan as Director

Consensus EPS estimates fall by 40%

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

At US$42.07, Is Stericycle, Inc. (NASDAQ:SRCL) Worth Looking At Closely?

Executive VP exercised options and sold US$109k worth of stock

An Intrinsic Calculation For Stericycle, Inc. (NASDAQ:SRCL) Suggests It's 40% Undervalued

These Return Metrics Don't Make Stericycle (NASDAQ:SRCL) Look Too Strong

President exercised options and sold US$189k worth of stock

Director recently bought US$287k worth of stock

Price target decreased by 8.5% to US$62.00

We Think Stericycle (NASDAQ:SRCL) Is Taking Some Risk With Its Debt

Full year 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Now 20% undervalued

What Is Stericycle, Inc.'s (NASDAQ:SRCL) Share Price Doing?

An Intrinsic Calculation For Stericycle, Inc. (NASDAQ:SRCL) Suggests It's 37% Undervalued

Stericycle, Inc. Appoints Naren K. Gursahaney to the Board of Directors, Effective January 1, 2023

Infomedia Group, Inc. acquired Stericycle Communication Solutions, Inc. from Stericycle, Inc. (NasdaqGS:SRCL) for $45 million.

These Return Metrics Don't Make Stericycle (NASDAQ:SRCL) Look Too Strong

Insufficient new directors

Stericycle's (NASDAQ:SRCL) Conservative Accounting Might Explain Soft Earnings

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

We Think Stericycle (NASDAQ:SRCL) Is Taking Some Risk With Its Debt

Stericycle: Muted Outlook, Fair Valuations

Price target decreased to US$65.20

Stericycle Q2 2022 Earnings Preview

Be Wary Of Stericycle (NASDAQ:SRCL) And Its Returns On Capital

Executive VP exercised options and sold US$93k worth of stock

Is Stericycle (NASDAQ:SRCL) A Risky Investment?

Stericycle: The Risks Outweigh The Reward

Insufficient new directors

Price target decreased to US$63.67

President exercised options and sold US$62k worth of stock

First quarter 2022 earnings: EPS misses analyst expectations

Capital Allocation Trends At Stericycle (NASDAQ:SRCL) Aren't Ideal

Stericycle, Inc., Annual General Meeting, May 26, 2022

Stericycle, Inc. Announces New Safeshield™ Medical Waste Containers

High number of new directors

Is Stericycle, Inc. (NASDAQ:SRCL) Trading At A 40% Discount?

President exercised options and sold US$169k worth of stock

Senior VP & Chief Accounting Officer exercised options and sold US$51k worth of stock

Stericycle, Inc. Provides Earnings Guidance for the Full-Year 2022

Full year 2021 earnings: EPS misses analyst expectations

Consensus forecasts updated

Third quarter 2021 earnings released: US$0.72 loss per share (vs US$0.89 loss in 3Q 2020)

President exercised options and sold US$70k worth of stock

Stericycle: A Neutral View

Second quarter 2021 earnings released: EPS US$0.32 (vs US$0.049 loss in 2Q 2020)

Revenue & Expenses Breakdown
Beta